Related Experiment Videos

Expression of involucrin in human middle ear cholesteatoma

W Y Chao1, C C Huang

  • 1Department of Otolaryngology, Columbia University College of Physicians and Surgeons, New York, New York 10032.

Insights

Involucrin, a protein indicating epidermal characteristics, is more abundant in middle ear cholesteatoma than in normal skin. This suggests active epithelial cell differentiation, potentially offering new treatment targets.

Area of Science:

  • Otolaryngology
  • Dermatology
  • Cell Biology

Background:

  • Middle ear cholesteatoma exhibits abnormal epithelial growth.
  • Involucrin is a key marker of epidermal differentiation.

Purpose of the Study:

  • To investigate the presence and distribution of involucrin in human middle ear cholesteatoma.
  • To compare involucrin levels in cholesteatoma with normal skin and external ear canal skin.

Main Methods:

  • Immunohistochemistry using rabbit anti-human involucrin antibody.
  • Quantitative analysis of involucrin staining in cholesteatoma, tympanic membrane, and external ear canal skin.

Main Results:

  • Involucrin was prominently detected in the cytoplasm of suprabasal cells in cholesteatoma.
  • Cholesteatoma showed significantly higher involucrin expression (60%) compared to external ear canal skin (29%) and normal skin (25%).
  • The distribution pattern of involucrin confirmed epidermal characteristics of cholesteatoma.

Conclusions:

  • Epithelial cells in middle ear cholesteatoma display active differentiation, as indicated by increased involucrin expression.
  • Targeting involucrin formation could be a potential therapeutic strategy for cholesteatoma.

Related Concept Videos